Stay updated with breaking news from Tolerance Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MIAMI, FL / ACCESSWIRE / March 1, 2023 / iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage regenerative medicine company developing technologies to enable tissue, organoid or cell therapy
- Live video webcast presentations with participating companies -FRENCHTOWN, NJ / ACCESSWIRE / January 11, 2023 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm
Sumitra Ghate promoted to Senior Vice President of Development & Global Regulatory Affairs to continue driving strategic regulatory and development programsDr. Esma S. Yolcu appointed as Chief Technical
/PRNewswire/ -- iTolerance, Inc., an early-stage regenerative medicine company developing technology to enable tissue, organoid or cell therapy without the...
Company advancing development of lead program, iTOL-101, as a potential breakthrough in curing Type 1 Diabetes with the potential to eliminate the need for chronic life-long immunosuppressionThe up to